Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients

Transplantation. 2009 Aug 27;88(4):597-8. doi: 10.1097/TP.0b013e3181b15d56.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Castleman Disease / etiology
  • Castleman Disease / immunology
  • Herpesvirus 8, Human / immunology
  • Herpesvirus 8, Human / isolation & purification
  • Humans
  • Liver Transplantation / adverse effects
  • Liver Transplantation / immunology
  • Lymphoma, Primary Effusion / etiology
  • Lymphoma, Primary Effusion / immunology
  • Protein Kinases / drug effects*
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / etiology
  • Sarcoma, Kaposi / virology
  • Sirolimus / therapeutic use*
  • T-Lymphocytes / immunology
  • TOR Serine-Threonine Kinases
  • Transplantation Immunology

Substances

  • Antibiotics, Antineoplastic
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus